Shengqiang Li
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$5.6MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $5.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 21, 2026 | NIH | SBIR Phase I Novel respiratory syncytial virus therapeutics targeting G-receptor binding | $314K | SCIOGEN, LLC |
| Mar 21, 2025 | NIH | SBIR Phase II Novel G protein-based RSV vaccine | $972K | SCIOGEN, LLC |
| Mar 21, 2024 | NIH | SBIR Phase II Novel G protein-based RSV vaccine | $996K | SCIOGEN, LLC |
| Apr 25, 2023 | NIH | SBIR Phase II Novel G protein-based RSV vaccine | $999K | SCIOGEN, LLC |
| Jul 12, 2021 | NIH | SBIR Phase I Optimization of G Protein-based RSV Vaccines | $299K | SCIOGEN, LLC |
| Jul 27, 2020 | NIH | SBIR Phase I Optimization of G Protein-based RSV Vaccines | $300K | SCIOGEN, LLC |
| Jul 24, 2018 | NIH | SBIR Phase II Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology | $302K | SCIOGEN, LLC |
| Jul 25, 2017 | NIH | SBIR Phase II Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology | $722K | SCIOGEN, LLC |
| Jul 29, 2016 | NIH | SBIR Phase II Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology | $738K | SCIOGEN, LLC |
Peer ranks
Federal funding#217
Awards as PI#151
Patents#273
Companies
- SCIOGEN, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.